Search

Linda Masat

age ~61

from New York, NY

Get Report
Also known as:
  • Linda T
Phone and address:
1619 3Rd Ave APT 25G, New York, NY 10128
Connected to:

Linda Masat Phones & Addresses

  • 1619 3Rd Ave APT 25G, New York, NY 10128
  • Jersey City, NJ
  • Redwood City, CA
  • Walnut Creek, CA
  • Oakland, CA
  • San Francisco, CA
  • 2728 San Antonio Dr, Walnut Creek, CA 94598

Work

  • Company:
    Takeda san francisco
    Dec 2008 to Jul 2012
  • Position:
    Director, antibody technologies

Education

  • Degree:
    Doctoral degree
  • School / High School:
    Università degli Studi di Urbino 'Carlo Bo'
  • Specialities:
    Biochemistry

Skills

Drug Discovery • Biotechnology • Monoclonal Antibodies • Antibodies • Assay Development

Industries

Pharmaceuticals
Name / Title
Company / Classification
Phones & Addresses
Linda Masat
Director
TAKEDA SAN FRANCISCO, INC
Commercial Physical Research
285 E Grade Ave, South San Francisco, CA 94080
1 Takeda Pkwy, Bannockburn, IL 60015
285 E Grand Ave, South San Francisco, CA 94080

Resumes

Linda Masat Photo 1

Vp, Business Development

view source
Location:
San Francisco, CA
Industry:
Pharmaceuticals
Work:
Takeda San Francisco Dec 2008 - Jul 2012
Director, Antibody Technologies
XOMA (US) LLC May 2003 - Nov 2008
Director, Antibody Discovery and Engineering
Abgenix, Inc. Jan 2000 - Apr 2003
Scientist
UCSF - San Francisco Bay Area Sep 1993 - Sep 1999
Postdoctoral fellow
Education:
Università degli Studi di Urbino 'Carlo Bo'
Doctoral degree, Biochemistry
Skills:
Drug Discovery
Biotechnology
Monoclonal Antibodies
Antibodies
Assay Development

Us Patents

  • Method Of Treating Or Preventing An Il-1 Related Disease Or Condition

    view source
  • US Patent:
    7582742, Sep 1, 2009
  • Filed:
    Jul 18, 2008
  • Appl. No.:
    12/218914
  • Inventors:
    Linda Masat - Oakland CA, US
    Mary Haak-Frendscho - Newark CA, US
    Gang Chen - San Diego CA, US
    Arnold Horwitz - San Leandro CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    XOMA Technology Ltd. - Berkeley CA
  • International Classification:
    C12N 5/10
    C12N 15/13
    C12N 15/63
  • US Classification:
    536 2353, 435325, 4352523, 4353201
  • Abstract:
    Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO:28, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide is provided. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

  • Method Of Treating An Il-1 Related Inflammatory Disease Or Condition

    view source
  • US Patent:
    7695717, Apr 13, 2010
  • Filed:
    Jul 18, 2008
  • Appl. No.:
    12/218997
  • Inventors:
    Linda Masat - Oakland CA, US
    Mary Haak-Frendscho - Newark CA, US
    Gang Chen - San Diego CA, US
    Arnold Horwitz - San Leandro CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    XOMA Technology Ltd. - Berkeley CA
  • International Classification:
    A61K 39/395
  • US Classification:
    4241411, 4241451, 4241391
  • Abstract:
    Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO:28, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide is provided. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

  • Il1-Β Binding Antibodies And Fragments Thereof

    view source
  • US Patent:
    7744865, Jun 29, 2010
  • Filed:
    May 11, 2009
  • Appl. No.:
    12/463741
  • Inventors:
    Linda Masat - Walnut Creek CA, US
    Mary Haak-Frendscho - Newark CA, US
    Arnold H. Horwitz - San Leandro CA, US
    Gang Chen - San Diego CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    Xoma Technology Ltd. - Berkeley CA
  • International Classification:
    C07K 16/24
    A61K 39/395
  • US Classification:
    424 852, 5303871, 5303881
  • Abstract:
    An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 8 and SEQ ID NO: 9, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

  • Il-1Β Binding Antibodies And Binding Fragments Thereof

    view source
  • US Patent:
    7744866, Jun 29, 2010
  • Filed:
    May 11, 2009
  • Appl. No.:
    12/463844
  • Inventors:
    Linda Masat - Walnut Creek CA, US
    Mary Haak-Frendscho - Newark CA, US
    Arnold H. Horwitz - San Leandro CA, US
    Gang Chen - San Diego CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    XOMA Technology Ltd. - Berkeley CA
  • International Classification:
    C07K 16/24
    A61K 39/395
  • US Classification:
    424 852, 5303871, 5303881
  • Abstract:
    An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 26 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

  • Method Of Treating An Il-1 Related Autoimmune Disease Or Condition

    view source
  • US Patent:
    7829093, Nov 9, 2010
  • Filed:
    May 11, 2009
  • Appl. No.:
    12/464006
  • Inventors:
    Linda Masat - Walnut Creek CA, US
    Mary Haak-Frendscho - Newark CA, US
    Arnold H. Horwitz - San Leandro CA, US
    Gang Chen - San Diego CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    Xoma Technology Ltd. - Berkeley CA
  • International Classification:
    A61K 39/395
  • US Classification:
    4241451, 4241301, 4241391, 4241411, 514885
  • Abstract:
    Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO: 15 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

  • Method Of Treating An Il-1 Related Cancer

    view source
  • US Patent:
    7829094, Nov 9, 2010
  • Filed:
    May 11, 2009
  • Appl. No.:
    12/464061
  • Inventors:
    Linda Masat - Walnut Creek CA, US
    Mary Haak-Frendscho - Newark CA, US
    Arnold H. Horwitz - San Leandro CA, US
    Gang Chen - San Diego CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    Xoma Technology Ltd. - Berkeley CA
  • International Classification:
    A61K 39/395
  • US Classification:
    4241451, 4241301, 4241391, 4241411, 514885
  • Abstract:
    Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO: 15 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

  • Prlr-Specific Antibody And Uses Thereof

    view source
  • US Patent:
    7867493, Jan 11, 2011
  • Filed:
    Aug 17, 2007
  • Appl. No.:
    11/840267
  • Inventors:
    Jason Damiano - Emeryville CA, US
    Mohammad Luqman - Emeryville CA, US
    Daniel Bedinger - Vacaville CA, US
    Linda Masat - Oakland CA, US
    Amer Mirza - San Francisco CA, US
    Genevieve Nonet - Berkeley CA, US
  • Assignee:
    Novartis AG - Basel
    Xoma Technology Ltd. - Berkeley CA
  • International Classification:
    A61K 39/395
    C07K 16/18
    G01N 33/566
    C12N 15/11
    C12N 5/06
    C12P 21/00
  • US Classification:
    4241331, 4241381, 4241781, 436501, 5303871, 5303913, 5303917
  • Abstract:
    PRLR-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.

  • Il-1Β Binding Antibodies And Fragments Thereof

    view source
  • US Patent:
    7943121, May 17, 2011
  • Filed:
    May 12, 2009
  • Appl. No.:
    12/464381
  • Inventors:
    Linda Masat - Walnut Creek CA, US
    Mary Haak-Frendscho - Newark CA, US
    Arnold H. Horwitz - San Leandro CA, US
    Gang Chen - San Diego CA, US
    Marina Roell - Concord CA, US
  • Assignee:
    XOMA Technology Ltd. - Berkeley CA
  • International Classification:
    C07K 16/24
    A61K 39/395
  • US Classification:
    424 852, 5303871, 5303881
  • Abstract:
    An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 2, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Get Report for Linda Masat from New York, NY, age ~61
Control profile